News | September 11, 2023
SÜDPACK Medica presents PharmaGuard at CPHI in Barcelona
SÜDPACK customers also benefit when it comes to processing PharmaGuard
SÜDPACK customers also benefit when it comes to processing PharmaGuard
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
The approval bolsters the company's Mycophenolate Mofetil portfolio
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Subscribe To Our Newsletter & Stay Updated
